Production, purification, and characterization of human α1 proteinase Inhibitor from aspergillus niger

Biotechnology and Bioengineering

Volumn 102, Issue 3, 2009, Pages 828-844

  Chill, Liat ^a   Trinh, Loc ^a   Azadi, Parastoo ^b   Ishihara, Mayumi ^b   Sonon, Roberto ^b   Karnaukhova, Elena ^c   Ophir, Yakir ^c   Golding, Basil ^c   Shiloach, Joseph ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Aspergillus niger; Glycosylation; L PI

Indexed keywords

CARBON; CLONING; DISSOLVED OXYGEN; GLYCOPROTEINS; GLYCOSYLATION; POLYSACCHARIDES; PROTEINS; PURIFICATION;

ASPERGILLUS NIGER; DISSOLVED OXYGEN CONCENTRATIONS; GALACTOFURANOSE; LINKAGE ANALYSIS; MONOSACCHARIDE ANALYSIS; PROTEINASE INHIBITORS; SUBMERGED CULTURE CONDITION; TYPICAL STRUCTURES;

ASPERGILLUS;

ALPHA 1 ANTITRYPSIN; DISSOLVED OXYGEN; GALACTOSE; GLYCAN; MANNOSE; N ACETYLGLUCOSAMINE; RECOMBINANT PROTEIN;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; ASPERGILLUS NIGER; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DETERMINATION; DRUG PURIFICATION; DRUG SYNTHESIS; FUNGUS CULTURE; IONIZATION; LINKAGE ANALYSIS; MASS FRAGMENTOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; MOLECULAR WEIGHT; NONHUMAN; OXYGEN CONCENTRATION; PH; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN VARIANT;

ASPERGILLUS NIGER; FUNGI;

EID: 60349083191     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22099     Document Type: Article

References (44)

1. Aoki K, Perlman M, Lim JM, Cantu R, Wells L, Tiemeyer M. 2007. Dynamic developmental elaboration of N-linked glycan complexity in the dro- sophila melanogaster embryo. J Biol Chem 282(12):9127-9142.
2. Archer DB, Pederby JF. 1997. The molecular biology of secreted enzyme production by fungi. Crit Rev Biotechnol 17:273-306.
3. Archer DB, Jeenes DJ, Mackenzie DA, Brightwell G, Lambert N, Lowe G, Radford SE, Dobson CM. 1990. Hen egg white lysozome expressed in, and secreted from, Aspergillus niger is correctly processed and folded. Biotechnology 8:741-745.
4. Beatty K, Beith J, Travis J. 1980. Kinetics of association of serine proteinase with native and oxidized a-1-proteinase inhibitor and a-1-antichymo- trypsin. J Biol Chem 225(9):3931-3934.
5. Beatty K, Matheson N, Travis J, Hoppe-Seyler SZ. 1984. Kinetic and chemical evidence for the inability of oxidized a-1-proteinase inhibitor to protect lung elastin from elastolytic degradation. Physiol Chem 365:731-736.
6. Broekhuijesen MP, Mattern IA, Contreras R, Kinghorn JR, van den Hondel CAMJJ. 1993. Secretion of heterologous proteins by Aspergillus niger: Productionofactive humaninterleukin-6in a protease-deficientmutant by KEX2-like processing of a glucoamylase-hIL6 fusion protein. J Biotech 31:135-145.
7. BurnoufT, Constans J, Clerc A, Descamps J, Martinache L, Goudemand M. 1987. Biochemical and biological properties of an a-1-antitrypsin concentrate. Vox Sang 52:291-297.
8. Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Boswell R. 1982. Structure and variation of human a1-antitrypsin. Nature 298:329-334.
9. Chen SX, Hammond DJ, Klos AM, Wood WD, Wydick JE, LebingWR. 1998. Chromatographic purification of human a1 proteinase inhibitor from dissolved Cohn fraction IV-1 paste. J Chromatogr A 800:207-218.
10. Ciucanu I, Kerek F. 1984. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 131:209-217.
11. Courtney M, Buchwalder A, Tessier L, Jaye M, Benavente A, Balland A, Kohli V, Lathe R, Tolstoshev P, Lecocq J. 1984. High level production of biologically active a-1-antitrypsine in Escherichia coli. Proc Natl Acad Sci USA 81:669-673.
12. Dean N. 1999. Asparagine-linked glycosylation in the yeast Golgi. Biochim Biophys Acta Gen Subj 1426:309-322.
13. Dunn-Coleman NS, Bloebaum P, Berka RM, Boore E, Robinson N, Armstrong G, Ward M, Przetak M, Carter GL, La Cost R, Wilson LJ, Kodama KH, Balu EF, Baver B, Lamsa M, Heinsohn H. 1991. Commercial levels of chymosin production by Aspergillus. Bio/Technol 9:976-981.
14. Guzdek A, Potempa J, Dubin A, Travis J. 1990. Comparative properties of human a-1-proteinase inhibitor glycosylation variants. FEBS Lett 272: 125-127.
15. Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, Bobrowicz B, Stadheim TA, Li H, Choi BK, Hopkins D, Wischnewski H, Roser J, Mitchell T, Strawbridge RR, Hoopes J, Wildt S, Gerngross TU. 2006. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 313:1441-1443.
16. Hardy MR, Townsend RR. 1994. High-pH anion-exchange chromatography of glycoprotein-derived carbohydrates. Methods Enzymol 230:208-225.
17. Honda G, Matsuda A, Zushi M, Yamamoto S, Komatsu K. 1997. Heterolo-gous protein production in Acremonium chrysogenum: expression of bacterial cephalosporin G acrylase and human thrombomodulin genes. Biosci Biotech Biochem 61:948-955.
18. Hsiao J, Ahluwalia M, Kaufman JB, Clem TR, Shiloach J. 1992. Adaptive control strategy for maintaining dissolved oxygen concentration in high density growth of recombinant E. coli. Ann NY Acad Sci 665:320-333.
19. Huang J, Sutliff TD, Wu L, Nandi S, Benge K, Terashima M, Ralston AH, Droham W, Huang N, Rodriguez RL. 2001. Expression and purification of functional human a-1-antitrypsin from cultured plant cells. Bio- technol Prog 17:126-133.
20. Karnaukhova E, Ophir Y, Trinh L, Dalal N, Punt PJ, Golding B, Shiloach J. 2007. Expression of human alpha-1-proteinase inhibitor in Aspergillus niger. Microbial Cell Factories 6(34):1-10.
21. 1-proteinase inhibitor products used for replacement therapy. Transfusion 46(11):1959-1977.
22. Kolarich D, Weber A, Turecek PL, Schwarz HP, Altmann F. 2006b. Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics 6(11):3369-3380.
23. Kwon KS, Song M, Yu MH. 1995. Purification and characterization of a1-antitrypsinsecretedbyrecombinantyeastSaccharomycesdiastaticus. J Biotechnol 42:191-195.
24. Lapadula AJ, Hatch PJ, Hanneman AJ, Ashline DJ, Zhang H, Reinhold VN. 2005. Congruent strategies for carbohydrate sequencing. 3. OSCAR: An algorithm for assigning oligosaccharide topology from MSn data. Anal Chem 77(19):6271-6279.
25. Manzanares P, de GraaffLH, Visser J. 1998. Characterization of galactosidase from Aspergillus niger: Purification of a novel alpha-galactosidase activity. Enzyme Microb Technol 22(5):383-390.
26. Maras M, Die IV, Contreras R, van den Hondel CAMJJ. 1999. Filamentous fungias production organisms for glycoproteins of bio-medical interest. J Glycoconjugate 16:99-107.
27. Mattes E, Matthiesson HP, Turecek PL, Schwarz HP. 2001. Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activity. Vox Sang 81:29-36.
28. Mikosch T, Klemm P, Gassen HG, van den Hondel CAMJJ, Kemme M. 1996. Secretion of active human mucus proteinase inhibitor by Aspergillus niger after KEX2-like processing of a glucoamylase-inhibitor fusion protein. J Biotech 52:97-106.
29. Morelle W, Bernard M, Debeaupuis JP, Buitrago M, Tabouret M, Latgé JP. 2005. Galactomanoproteins of Aspergillus fumigatus. Eukaryot Cell 4(7):1308-1316.
30. Punt PJ, van den Hondel CAMJJ. 1992. Transformation of filamentous fungi based on hygromycin B and phleomycin resistance markers. Methods Enzymol 216:447-457.
31. Punt PJ, van Biezen N, Conesa A, Albers A, Mangnus J, van den Hondel CAMJJ. 2002. Filamentous fungi as cell factories for heterologous protein production. Trends Biotechnol 20:200-206.
32. Roberts IN, Jeenes DJ, MacKenzie DA, Wilkinson AP, Sumner IG, Archer DB. 1992. Heterologous gene expression in Aspergillus niger: A glucoamylase-porcine pancreatic prophospholipase A2 fusion protein is secreted and processed toyield mature enzyme. Gene 122:155-161.
33. Takayanagi T, Kimura A, Chiba S, Ajisaka K. 1994. Novel structure of N-linked high mannose type oligosaccharides containing alpha D- galactofuranosyl linkages in Aspergillus niger alpha-D-glucosidase. Carbohydr Res 256(1):149-158.
34. Travis J, Owen M, George P, Carrell R, Rosenberg S, Hallewell RA, Barr PJ. 1985. Isolation and properties of recombinant DNA produced variants of Human a1-proteinase inhibitor. J Biol Chem 260:4384-4389.
35. van de Hombergh JP, van de Vondervoort PJ, van de Heijden NC, Visser J. 1995. Newprotease mutants in Aspergillus niger result in strong reduced in vitro degradation of target proteins; genetical and biochemical characterization of seven complementation groups. Curr Genet 28(4):299-308.
36. Van Gorcom RFM, Hertingsveldt WLA, Paridon PAB, Veenstra AEN, Lulten RGM, Selton GCM. 1990. Cloning and expression of microbial phytase. European Patent Application 0420 358 A1.
37. Wallis GL, Easton RL, Jolly K, Hemming FW, Peberdy JF. 2001. Galactofuranoic-oligomannose N-linked glycans of alpha-galactosidase A from Aspergillus niger. Eur J Biochem 268(15):4134-4143.
38. Ward PP, Piddington CS, Cunningham GA, Zhou X, Wyatt RD, Conneely OM. 1995. A system for production of commercial quantities of human lactoferrin: A broad spectrum natural antibiotic. Biotechnology 13:498-503.
39. Ward M, Lin C, Victoria DC, Fox BP, Fox JA, Wong DL, Meerman HJ, Pucci JP, Fong RB, Heng MH, Tsurushita N, Gieswein C, Park M, Wang H. 2004. Characterization of humanized antibodies secreted byAspergillus niger. Appl Envir Microbi 70(5):2567-2576
40. Wiebe MG, Karandikar A, Robson GD, Trinci AP, Candia JLF, Trappe S, Wallis G, Rinas U, Derkx PMF, Madrid SM, Sisniega H, Faus I, Montijn
41. R, van den Hondel CAMJJ, Punt PJ. 2001. Production of tissue plas- minogen activator (t-PA) in Aspergillus niger. Biotech Bioeng 76:164-174.
42. Woosley B, Xie M, Wells L, Orlando R, Garrison D, KingD, Bermann C. 2006. Comprehensive glycan analysis of recombinant Aspergillus niger endo-polygalacturonase. Anal Biochem 354:43--53.
43. Wright G, Carver A, Cottom D, Reeves D, Scott A, Simons P, Wilmut I, Garner I, Colman A. 1991. High level of active human alpha-1-anti-trypsin in the milk of transgenic sheep. Biotechnology 9:830--834.
44. Zbikowska HM, Soukhareva N, Behnam R, Lubon H, Hammond DJ, Soukharev S. 2002. Uromodulin promoter directs high-level expression of biologicallyactive human a1-antitrypsin into mouse urine. Biochem J 365:7-11.